Vertex Pharmaceuticals Inc VRTX:NASDAQ

Last Price$216.90Cboe Real-Time Last Sale as of 1:19PM ET 11/22/19
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change+1.40(0.65%)
Bid (Size)$216.87 (103)
Ask (Size)$216.97 (100)
Day Low / High$215.25 - 217.55
Volume694.4 K

Insider Trends: Selling By Insiders Lingers at Vertex Pharmaceuticals

4:27PM ET 10/03/2019 MT Newswires
Ourania Tatsis, SVP, Cro, sold 632 shares in Vertex Pharmaceuticals (VRTX) for $106,247 on Oct 01, 2019. Tatsis, after the transactions delineated in the SEC Form 4 filing, owns 7,252 shares of company stock, with a market value, based on the prior-day closing price, of $1.21 million.

Over the last 90 days, previous to the date of this filing, there have been 14 insider transactions reported to the SEC for Vertex Pharmaceuticals. These transactions came from the activities of 4 different insiders that resulted in no change to insider holdings with acquisitions exactly offset by dispositions of company shares. Relative to the preceding 90-day window of time, there were 35 transactions from 15 insiders which resulted in the net disposition of 486 shares.

This level of insider transactions is less than the peer group average in the 324-company Bio Therapeutic Drugs peer group over the last 90-day period. Activity in the peer group averaged 38.0 transactions per company, with company insiders acquiring on average 15,943 shares.

SEC Story Link